About Us


Medical Therapies Limited (MTY) is an Australian pharmaceutical development company committed to the commercialisation of its drug candidates for a range of anti-inflammatory conditions.

Medical Therapies' focus is to reformulate or re-profile existing drugs and prove these new candidates up for therapeutic use by demonstrating improved safety and/or efficacy in certain conditions.

The Company's lead drug candidate, Cuprindo™, has shown encouraging results in pre-clinical trials. Cuprindo™ has been developed using MTY's patent-protected technologies which originate from The University of Sydney and include a number of metal complexes of non-steroidal anti-inflammatory drugs showing increased safety and reduced toxicity in pre-clinical trials.